Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs present new challenges.

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Carlos Gershenson, Binghamton University, State University of New York (THE ...

Decisions made today will have stark consequences in 25 years. A panel of experts offer their predictions on politics, health ...

The publication unveiled its annual selection of the most significant scientific and technological breakthroughs from the ...

Tiny lab-grown “mini brains” are no longer just a futuristic curiosity. By capturing the electrical chatter of neurons in a ...

Every Christmas, Christians celebrate the birth of a child born into oppression – an occupied land, a climate of political ...

The institute Fried is founding at Reichman University will explore more than direct brain stimulation and hybrid brains. "We’re bringing together people from different disciplines to examine all ...

For decades, schizophrenia and bipolar disorder have been diagnosed from the outside in, through behavior, mood, and memory ...

This article looks at some of the latest developments in biotech letters, exploring how new tools are helping us solve big problems and what it takes to get these ideas out of the lab and into the ...

Automation in healthcare means using smart technology, like computers and robots, to do tasks that people used to do. This can include helping doctors find sicknesses, performing surgeries, or even ...

This study presents SynaptoGen, a differentiable extension of connectome models that links gene expression, protein-protein interaction probabilities, synaptic multiplicity, and synaptic weights, and ...

WIRED spoke with DeepMind’s Pushmeet Kohli about the recent past—and promising future—of the Nobel Prize-winning research ...